The Joint Mobile Emerging Disease Clinical Capability (JMEDICC) laboratory approach: Capabilities for high-consequence pathogen clinical research

Following the 2013–2016 Ebola virus outbreak in West Africa, numerous groups advocated for the importance of executing clinical trials in outbreak settings. The difficulties associated with obtaining reliable data to support regulatory approval of investigational vaccines and therapeutics during tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Naluyima, Prossy, Kayondo, Willy, Ritchie, Chi, Wandege, Joseph, Kagabane, Sharon, Tumubeere, Lydia, Kusiima, Brenda, Kibombo, Daniel, Atukunda, Sharon, Nanteza, Christine, Nabirye, Harriet, Mugabi, Francis Bunjo, Namuyanja, Sarah, Hatcher, Christopher, Rauch, Hypaitia, Mukembo, Moses, Musinguzi, Patrick, Sanders, Nathan, Turesson, Elizabeth, Cando, Christian, Walwema, Richard, Mimbe, Derrick, Hepburn, Janice, Clark, Danielle, Lamorde, Mohammed, Kibuuka, Hannah, Zaman, Saima, Cardile, Anthony P., Martins, Karen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922336/
https://www.ncbi.nlm.nih.gov/pubmed/31856153
http://dx.doi.org/10.1371/journal.pntd.0007787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922336/
https://www.ncbi.nlm.nih.gov/pubmed/31856153
http://dx.doi.org/10.1371/journal.pntd.0007787

Ejemplares similares